Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
Liu X, Zhang X, Zhang Z, Chang J, Wang Z, Wu Z, Wang C, Sun Z, Ge X, Geng R, Tang W, Dai C, Lin Y, Lin F, Sun M, Jia W, Xue W, Ji J, Hu Y, Qin G, Li J.
Liu X, et al.
Int J Cancer. 2017 Nov 15;141(10):2093-2102. doi: 10.1002/ijc.30895. Epub 2017 Jul 28.
Int J Cancer. 2017.
PMID: 28722210
Free article.